ZBH

#615
Zimmer Biomet Holdings, Inc. Common Stock
100.0 1 USD
-0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
99.96
100.29
Intervallo Annuale
79.12
103.69
Variazione giornaliera
-0.90%
Variazione Mensile
+4.12%
Variazione di 6 mesi
+3.25%
Variazione Annuale
-3.37%
Chiusura Precedente
100.9 2
Open
100.0 0
Minimo
99.9 6
Massimo
100.2 9
Volume
581
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi Documents

2026

Current report, Q3 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
ZIMMER BIOMET HOLDINGS, INC. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q1 FY2026
8-K

ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2012

Full document

Business Context and Reporting Period

Company: Zimmer Holdings, Inc. (Note: Filing lists "Zimmer Holdings, Inc."; user metadata references "Zimmer Biomet Holdings, Inc.")
Filing Type: Form 8-K (Current Report)
Date of Report: May 24, 2012
Event: Entry into a Material Definitive Agreement involving a new term loan and guarantee.

Key Financial Metrics

  • New Debt Instrument: Yen 11.7 billion term loan.
  • Lender: Sumitomo Mitsui Banking Corporation.
  • Borrower: Zimmer K.K. (wholly-owned subsidiary).
  • Interest Rate: Fixed at 0.61% per annum.
  • Maturity Date: May 31, 2016.
  • Use of Proceeds: Repayment of Yen 11.7 billion in outstanding borrowings under the existing $1.35 billion Credit Agreement dated May 9, 2012.
  • Guarantee: The Company has unconditionally guaranteed the Borrower's obligations via a Letter of Guarantee.
  • Financial Covenants: Maximum leverage ratio of 3.0 to 1.0.

Material Changes

The filing reports a refinancing transaction rather than a change in operational performance. The Company replaced existing borrowings under its Credit Agreement with a new fixed-rate term loan denominated in Japanese Yen. This action alters the debt structure and interest rate profile for the specific Yen-denominated portion of the debt but does not change the total principal amount outstanding for that specific tranche.

Outlook, Risks, and Contingencies

  • Credit Rating Contingency: If the Company falls below an investment-grade credit rating, additional restrictions will apply, including limitations on investments and the ability to pay dividends.
  • Covenants: The agreement includes customary affirmative and negative covenants and events of default for an unsecured financing arrangement, including limitations on consolidations, mergers, and sales of assets.
  • Management Commentary: The filing contains no forward-looking guidance or management commentary regarding future earnings or operational strategy beyond the terms of the loan agreement.

Investor Verification Checklist

  • Verify the exact exchange rate used to convert the Yen 11.7 billion loan into USD for consolidated balance sheet reporting.
  • Confirm the Company's current leverage ratio to ensure compliance with the 3.0 to 1.0 covenant.
  • Review the full text of the Loan Agreement (Exhibit 10.1) and Letter of Guarantee (Exhibit 10.2) for specific default triggers.
  • Monitor the Company's credit rating status to assess potential restrictions on dividends.

Notizie